189 related articles for article (PubMed ID: 32871923)
1. Clinical evaluation of traditional Chinese medicine on mild active ulcerative colitis: A multi-center, randomized, double-blind, controlled trial.
Kou FS; Shi L; Li JX; Wang ZB; Shi R; Mao TY; Ke X; Zhang BP; Yang XJ; Wen XL; Zheng WY; Han X; Ding PH; Dong J
Medicine (Baltimore); 2020 Aug; 99(35):e21903. PubMed ID: 32871923
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of Fufangkushen colon-coated capsule in the treatment of ulcerative colitis compared with mesalazine: a double-blinded and randomized study.
Gong Y; Zha Q; Li L; Liu Y; Yang B; Liu L; Lu A; Lin Y; Jiang M
J Ethnopharmacol; 2012 Jun; 141(2):592-8. PubMed ID: 21911045
[TBL] [Abstract][Full Text] [Related]
3. Chinese herbal extract granules combined with 5-aminosalicylic acid for patients with moderately active ulcerative colitis: study protocol for a multicenter randomized double-blind placebo-controlled trial.
Shen Z; Zheng K; Zou J; Gu P; Xing J; Zhang L; Zhu L; Shen H
Trials; 2021 Jan; 22(1):55. PubMed ID: 33441157
[TBL] [Abstract][Full Text] [Related]
4. Mesalazine Modified-Release Tablet in the Treatment of Ulcerative Colitis in the Active Phase: A Chinese, Multicenter, Single-Blind, Randomized Controlled Study.
Sun J; Yuan Y
Adv Ther; 2016 Mar; 33(3):400-9. PubMed ID: 26898569
[TBL] [Abstract][Full Text] [Related]
5. Effect of Kangfuxin Liquid enema combined with mesalazine on gestational outcomes and quality of life in child-bearing female with active ulcerative colitis: A protocol for randomized, double-blind, controlled trial.
Wang T; Lu H; Li F; Zhang Q
Medicine (Baltimore); 2021 Feb; 100(5):e23915. PubMed ID: 33592844
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative Colitis.
Naganuma M; Sugimoto S; Mitsuyama K; Kobayashi T; Yoshimura N; Ohi H; Tanaka S; Andoh A; Ohmiya N; Saigusa K; Yamamoto T; Morohoshi Y; Ichikawa H; Matsuoka K; Hisamatsu T; Watanabe K; Mizuno S; Suda W; Hattori M; Fukuda S; Hirayama A; Abe T; Watanabe M; Hibi T; Suzuki Y; Kanai T;
Gastroenterology; 2018 Mar; 154(4):935-947. PubMed ID: 29174928
[TBL] [Abstract][Full Text] [Related]
7. Traditional Chinese medicine for mild-to-moderate ulcerative colitis: Protocol for a network meta-analysis of randomized controlled trials.
Shen Z; Zhou Q; Ni Y; He W; Shen H; Zhu L
Medicine (Baltimore); 2019 Aug; 98(33):e16881. PubMed ID: 31415431
[TBL] [Abstract][Full Text] [Related]
8. The efficacy and safety of Chinese herbal medicine Shen-Qi Hua-Yu formula in patients with diabetic lower extremity artery disease: Study protocol of a multi-center, randomized, double-blind, placebo-controlled trial.
Leng Y; Gao H; Fu X; Xie H; Hu Z; Zhu J; Liu X; Zhou X; Xie Z; Xie C
Medicine (Baltimore); 2020 Jan; 99(3):e18713. PubMed ID: 32011447
[TBL] [Abstract][Full Text] [Related]
9. Lyophilised oral faecal microbiota transplantation for ulcerative colitis (LOTUS): a randomised, double-blind, placebo-controlled trial.
Haifer C; Paramsothy S; Kaakoush NO; Saikal A; Ghaly S; Yang T; Luu LDW; Borody TJ; Leong RW
Lancet Gastroenterol Hepatol; 2022 Feb; 7(2):141-151. PubMed ID: 34863330
[TBL] [Abstract][Full Text] [Related]
10. Randomised clinical trial: Efficacy and safety of Qing-Chang-Hua-Shi granules in a multicenter, randomized, and double-blind clinical trial of patients with moderately active ulcerative colitis.
Shen H; Zhang S; Zhao W; Ren S; Ke X; Gu Q; Tang Z; Xie J; Chen S; Chen Y; Zou J; Zhang L; Shen Z; Zheng K; Liu Y; Gu P; Cheng J; Hu J; Zhu L
Biomed Pharmacother; 2021 Jul; 139():111580. PubMed ID: 33857914
[TBL] [Abstract][Full Text] [Related]
11. Curcumin-QingDai Combination for Patients With Active Ulcerative Colitis: A Randomized, Double-Blinded, Placebo-Controlled Trial.
Ben-Horin S; Salomon N; Karampekos G; Viazis N; Lahat A; Ungar B; Eliakim R; Kuperstein R; Kriger-Sharabi O; Reiss-Mintz H; Yanai H; Dotan I; Zittan E; Maharshak N; Hirsch A; Weitman M; Mantzaris GJ; Kopylov U
Clin Gastroenterol Hepatol; 2024 Feb; 22(2):347-356.e6. PubMed ID: 37302449
[TBL] [Abstract][Full Text] [Related]
12. Safety and efficacy of a new 3.3 g b.i.d. tablet formulation in patients with mild-to-moderately-active ulcerative colitis: a multicenter, randomized, double-blind, placebo-controlled study.
Scherl EJ; Pruitt R; Gordon GL; Lamet M; Shaw A; Huang S; Mareya S; Forbes WP
Am J Gastroenterol; 2009 Jun; 104(6):1452-9. PubMed ID: 19491859
[TBL] [Abstract][Full Text] [Related]
13. The efficacy and safety of Jian-Wei-Qu-Tong Pills for the treatment of chronic non-atrophic gastritis (spleen and stomach qi deficiency with damp-heat stasis syndrome): study protocol for a phase II, randomized controlled trial.
Zhang XX; Chen WW; She B; Luo RJ; Shi N; Xue P; Yang XN; Xia Q
Trials; 2014 Jul; 15():272. PubMed ID: 25002101
[TBL] [Abstract][Full Text] [Related]
14. Mesalazine Modified-Release Tablet in the Treatment of Ulcerative Colitis in the Remission Phase: A Chinese, Multicenter, Single-Blind, Randomized Controlled Study.
Sun J; Yuan Y
Adv Ther; 2016 Mar; 33(3):410-22. PubMed ID: 26905266
[TBL] [Abstract][Full Text] [Related]
15. A multi-center, randomized, single-blind, controlled clinical study on the efficacy of composite sophora colon-soluble capsules in treating ulcerative colitis.
Tong ZQ; Yang B; Chen BY; Zhao ML
Chin J Integr Med; 2010 Dec; 16(6):486-92. PubMed ID: 21110172
[TBL] [Abstract][Full Text] [Related]
16. Transfer of FRozen Encapsulated multi-donor Stool filtrate for active ulcerative Colitis (FRESCO): study protocol for a prospective, multicenter, double-blind, randomized, controlled trial.
Stallmach A; Grunert P; Stallhofer J; Löffler B; Baier M; Rödel J; Kiehntopf M; Neugebauer S; Pieper DH; Junca H; Tannapfel A; Merkel U; Schumacher U; Breternitz-Gruhne M; Heller T; Schauer A; Hartmann M; Steube A
Trials; 2022 Feb; 23(1):173. PubMed ID: 35193638
[TBL] [Abstract][Full Text] [Related]
17. Combined diosmectite and mesalazine treatment for mild-to-moderate ulcerative colitis: a randomized, placebo-controlled study.
Jiang XL; Wang HH; Cui HF
Med Sci Monit; 2015 Jan; 21():163-70. PubMed ID: 25582578
[TBL] [Abstract][Full Text] [Related]
18. A Phase 2a, Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Trial of IBD98-M Delayed-Release Capsules to Induce Remission in Patients with Active and Mild to Moderate Ulcerative Colitis.
Fiorino G; Sturniolo GC; Bossa F; Cassinotti A; di Sabatino A; Giuffrida P; Danese S
Cells; 2019 May; 8(6):. PubMed ID: 31151306
[TBL] [Abstract][Full Text] [Related]
19. Cannabis for the treatment of ulcerative colitis.
Kafil TS; Nguyen TM; MacDonald JK; Chande N
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD012954. PubMed ID: 30406638
[TBL] [Abstract][Full Text] [Related]
20. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
